Genesis Biotechnology Group has completed the acquisition of PharmOptima, which will enable the former to provide its customers a single point-of-contact for the development and co-ordination of their unique pre-clinical drug development programme.
The acquirer company is a US-based biotechnology firm, whereas the target company is a contract research organisation also based in the US.
Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma.
Both companies involved in the transaction are pharmaceutical organisations based in China.
The purchase consideration for the acquisition is expected to be ¥371.6m ($54.08m).
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData